FDA authorizes emergency use of Eli Lilly's monoclonal antibody treatment
HEALTH
February 10, 20212 min read397 words

FDA authorizes emergency use of Eli Lilly's monoclonal antibody treatmentFDA authorizes emergency use of Eli Lilly's monoclonal antibody treatment

 in 
Published: February 10, 2021  |  2 min read397 words
The FDA on Tuesday approved the monoclonal antibodies bamlanivimab and etesevimab for use against COVID-19, as they were specifically directed against a protein present in the coronavirus and are designed to block its attachment to human cells. Photo courtesy of /FlickrThe U.S. o...
FDA authorizes emergency use of Eli Lilly's monoclonal antibody treatment Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.